Drug Development, Hospitals and Packaging

Aspire Impact and Aspire Circle launch ESG Framework for Pharma & Healthcare

Express Pharma

JULY 15, 2025

The gathering brought together senior representatives from hospitals, pharmaceutical companies, policymakers, and ESG leaders, including Fortis, Apollo, Quadria Capital, and Tata Capital Healthcare Fund. The report was released at an event held in New Delhi, supported by Quadria Capital and HealthQuad.

Hospitals

Hospitals Packaging Pharmaceutical Companies Pharmaceutical Companies

Pharmacist to Clinical Strategy Leader: Brendan Doran on Building a Career in Biotech

The Nontraditional Pharmacist

JULY 1, 2025

And those are sites, sometimes those are hospitals, sometimes they’re physician’s offices, there’s for-profit, clinical research sites out there. And even just 10 minutes ago before we got on the call, I was looking up a drug. It’s a lot of taking these protocols and then going out and making sure we can find sites.

Hospitals

Hospitals Packaging Documentation Biosimilars

Lisata collaborates with GATC Health on drug development

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development.

Drug Development

Drug Development Communication Hospitals Packaging

EC approves argenx’s efgartigimod alfa for CIDP treatment

Pharmaceutical Technology

JUNE 23, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

Pharmaceutical Technology

JUNE 25, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

Pharmaceutical Technology

JULY 1, 2025

Experts praise the reforms to rare disease and antimicrobial research, but they worry that some provisions in the EU Pharma Package may harm innovation on the continent, contrary to its stated objectives. Go deeper with GlobalData Reports Chemotherapy in Pharmaceuticals: Platinum-based cancer drug composi.

Packaging

Packaging Drug Development Chemotherapy Biosimilars

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Pharmaceutical Technology

JUNE 19, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Packaging Hospitals

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

JUNE 27, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Labelling

Labelling Packaging Communication Hospitals

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

JUNE 20, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Vaccines

Vaccines Pharmaceutical Manufacturing Communication Hospitals

Harbour BioMed partners Otsuka on new T-cell therapy

Pharmaceutical Technology

JUNE 23, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Hospitals

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

Pharmaceutical Technology

JULY 16, 2025

The first drug developed employing this technology has received approval in Japan for treating a lysosomal storage disorder. Anticipated next steps involve generating preclinical candidate data packages, which will include non-human primate studies expected in early 2026. How will RFK Jr’s American dream for vaccines play out?

Packaging

Packaging Communication Hospitals Drug Development

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Pharmaceutical Technology

JULY 18, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Pricing

Madrigal poised to enter European MASH market after CHMP endorsement

Pharmaceutical Technology

JUNE 20, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Communication Hospitals Packaging

Novartis concludes Regulus Therapeutics acquisition

Pharmaceutical Technology

JUNE 26, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

Revolution Medicines partners Royalty Pharma on $2bn funding

Pharmaceutical Technology

JUNE 25, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

The unsustainability of clinical trials and need for transformative change

Pharmaceutical Technology

JULY 11, 2025

The present clinical trial ecosystem is not equipped nor projected to have the capacity to satisfy this demand, and as a result the ecosystem is facing a potential slowdown in drug development. This is despite the majority of patients being treated at community hospitals and clinics.

Drug Pricing

Drug Pricing Hospitals Medical Records Drug Development

Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model

PharmaTech

JUNE 19, 2025

Fabian Gerlinghaus, CEO of Cellares; Alexander Seyf, co-founder and CEO of Autolomous; and Knut Steffensen, director of the Karolinska Institutet and University Hospital ATMP Center, offer their perspectives on the urgent need for better integration across the therapeutic value chain. References 1. April 14, 2025, LinkedIn Post.

Dosage

Dosage Drug Development Vaccines Hospitals

Actio gains $66m to advance small molecule therapeutics pipeline

Pharmaceutical Technology

JUNE 19, 2025

Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Drug Development Pharmaceutical Manufacturing

FDA publishes more than 200 archived CRLs for transparency

Pharmaceutical Technology

JULY 11, 2025

FDA Commissioner Marty Makary stated: “For far too long, drug developers have been playing a guessing game when navigating the FDA. Drug developers and capital markets alike want predictability. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Communication

Communication Packaging Hospitals Drug Development

CTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignment

Pharmaceutical Technology

JULY 9, 2025

Initiatives such as Project Optimus emerged from the need for more rigorous dose-finding studies early in drug development. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Hospitals Communication Drug Pricing

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

Pharmaceutical Technology

JUNE 23, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

UK government targets manufacturing as it eyes £41bn life science sector growth

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Pricing

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Pharmaceutical Technology

JUNE 25, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Labelling

Labelling Packaging Communication Hospitals

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Pharmaceutical Technology

JUNE 19, 2025

Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drug development in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Drug Development Pharmaceutical Manufacturing

Vor Bio back from brink with autoimmune drug deal rising to $4bn

Pharmaceutical Technology

JUNE 26, 2025

A month and a half after winding operations and laying off almost all its staff, Vor Bio has emerged from the brink with a licensing deal potentially rising to $4bn for an autoimmune drug developed by Chinese biotech RemeGen. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Pharmaceutical Technology

JUNE 24, 2025

June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Fluimucil IV is now available to patients across China as an essential hospital-based treatment for respiratory conditions. By GlobalData Learn more about Strategic Intelligence The Phase I study involved healthy volunteers and was conducted at Ruijin Hospital.

Hospitals

Hospitals Packaging Communication Pharmaceutical Manufacturing

Navamedic signs agreement to acquire dne pharma

Pharmaceutical Technology

JUNE 24, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Pharmaceutical Manufacturing

Draig secures $140m for neuropsychiatric disorder therapies

Pharmaceutical Technology

JUNE 19, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

Vertex and NHS England agree reimbursement for Alyftrek

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Vaccines

Health Canada extends Evkeeza approval for children with HoFH

Pharmaceutical Technology

JULY 15, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Vaccines

NSW government invests $13.39m in life-changing therapies

Pharmaceutical Technology

JUNE 20, 2025

June 20, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The treatments can be accessed through facilities such as Royal Prince Alfred Hospital, Westmead Hospital and the Sydney Children’s Hospitals Network. Credit: Bohbeh creations/Shutterstock. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing

Insurance Coverage and Processing Hospitals Communication Pharmaceutical Manufacturing

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging

Packaging Hospitals Communication Research Laboratories

Enhancing solubility of targeted protein degraders: Better strategies for bioavailability

Pharmaceutical Technology

JULY 10, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest E. Achieving good oral bioavailability for TPDs Rebecca Coutts is Senior Director of Pharmaceutical Development at PCI Pharma Services, a world leading CDMO providing integrated end-to-end drug development.

Packaging

Packaging Communication Pharmaceutical Companies Pharmaceutical Companies

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Pharmaceutical Technology

JUNE 19, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Communication Hospitals Pharmaceutical Manufacturing Packaging

Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal

Pharmaceutical Technology

JUNE 25, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Packaging

Packaging Communication Hospitals Drug Development

NextCure and Simcere partner to develop SIM0505 for solid tumours

Pharmaceutical Technology

JUNE 17, 2025

. “SIM0505 is a significantly differentiated CDH6 targeting ADC candidate independently developed by Simcere Zaiming. Our alliance reflects NextCure’s recognition of our proprietary ADC platform, and together, we aim to accelerate drug development to benefit more cancer patients worldwide.”

Communication

Communication Hospitals Packaging Drug Development

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Pharmaceutical Technology

JULY 9, 2025

JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.

Insurance Coverage and Processing

Insurance Coverage and Processing Packaging Communication Hospitals

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Pharmaceutical Technology

JUNE 24, 2025

Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Compounding

Compounding Packaging Online Pharmacies Communication

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

Pharmaceutical Technology

JULY 14, 2025

Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Labelling

Labelling Vaccines Insurance Coverage and Processing Packaging

GSK’s Blenrep US comeback hindered by eye safety concerns

Pharmaceutical Technology

JULY 16, 2025

How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Documentation

Documentation Communication Packaging Hospitals

UK Government reveals 10-year plan for NHS

Pharmaceutical Technology

JULY 3, 2025

Calling such venues the “future of the health service”, Starmer said: “Hospitals will always be important, but disease has changed, and we must change with it. How will RFK Jr’s American dream for vaccines play out? Plans would shift the NHS towards being more of a community service, with the introduction of new community health centres.

Health and Personal Care Stores

Health and Personal Care Stores Hospitals Packaging Communication

FDA Commissioner envisions fewer delays, more clinical trial flexibility and AI use

Pharmaceutical Technology

JUNE 18, 2025

Reports Use of Artificial Intelligence in Pharmaceutical Drug Development a. Reports Use of Artificial Intelligence in Pharmaceutical Drug Development a. Go deeper with GlobalData Reports Outlook for Viral Vector Contract Manufacturing - Gene Therapies, C. Data Insights The gold standard of business intelligence.

Vaccines

Vaccines Communication Hospitals Drug Development

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Pharmaceutical Technology

JULY 15, 2025

LaNova’s drug development focuses on tumour immunity and the tumour microenvironment. The company has particular emphasis on antibody-drug conjugates (ADCs) and has built several platforms within this modality. How will RFK Jr’s American dream for vaccines play out? The share price in the company had climbed 3.6%

Packaging

Packaging Communication Hospitals Drug Development

Aspire Impact and Aspire Circle launch ESG Framework for Pharma & Healthcare

Pharmacist to Clinical Strategy Leader: Brendan Doran on Building a Career in Biotech

Trending Sources

Lisata collaborates with GATC Health on drug development

EC approves argenx’s efgartigimod alfa for CIDP treatment

FDA approves Sanofi and Regeneron’s Dupixent for bullous pemphigoid

EU’s Pharma Package falls short of Europe’s goal of global competitiveness

CNS innovator oligonucleotide licensing value up 339% from £2bn in 2024

Porton Advanced and EVA Pharma collaborate for CAR T-cell therapies

FDA approves label updates for BMS’ CAR T cell therapies

DoH – Abu Dhabi and Sanofi link for vaccine development

Harbour BioMed partners Otsuka on new T-cell therapy

Acumen and JCR partner on brain delivery therapy for Alzheimer’s

MHRA approves needle-free adrenaline nasal spray for anaphylaxis

Madrigal poised to enter European MASH market after CHMP endorsement

Novartis concludes Regulus Therapeutics acquisition

Revolution Medicines partners Royalty Pharma on $2bn funding

The unsustainability of clinical trials and need for transformative change

Behind the Headlines, Episode 19: CGT Cost Pressures, BioNTech’s CureVac Move, and Spain’s CAR-T Model

Actio gains $66m to advance small molecule therapeutics pipeline

FDA publishes more than 200 archived CRLs for transparency

CTO East Coast 2025: Navigating shifting regulatory environment hinges on close alignment

Bayer’s Eylea market grip set to slip as Alvotech biosimilar closes in

UK government targets manufacturing as it eyes £41bn life science sector growth

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Vor Bio back from brink with autoimmune drug deal rising to $4bn

Zambon gains Chinese regulatory authority approval for Fluimucil IV

Navamedic signs agreement to acquire dne pharma

Draig secures $140m for neuropsychiatric disorder therapies

Vertex and NHS England agree reimbursement for Alyftrek

Health Canada extends Evkeeza approval for children with HoFH

NSW government invests $13.39m in life-changing therapies

FDA to review MSD’s doravirine/islatravir NDA for HIV-1

Enhancing solubility of targeted protein degraders: Better strategies for bioavailability

BioOrbit eyes 2026 for pre-clinical trials of space manufactured protein crystals

Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal

NextCure and Simcere partner to develop SIM0505 for solid tumours

JCR Pharma and Alexion partner on JUST-AAV gene therapy platform

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

GSK eyes FDA label expansion for RSV vaccine Arexvy to include younger patients

GSK’s Blenrep US comeback hindered by eye safety concerns

UK Government reveals 10-year plan for NHS

FDA Commissioner envisions fewer delays, more clinical trial flexibility and AI use

Sino Biopharma spends $951m to acquire China-based LaNova Medicines

Stay Connected